Curiox Biosystems Strengthens Strategic Partnership with TOMY Digital Biology, Deepening Presence in Japan’s Bio Research Market

SEOUL, Korea — Curiox Biosystems proudly announced on the 14th that it has expanded its strategic partnership with TOMY DIGITAL BIOLOGY CO., LTD. (TOMY), a leading Japanese distributor of advanced bio equipment and reagents, through the recent sale of the Pluto LT workstation on the 7th.

TOMY has established itself with over 60 years of extensive experience and a long-established network in bioresearch equipment and reagents, solidifying its executive presence in this critical space. The company is renowned for distributing specialized systems, including prominent brands and high-precision flow cytometry instruments, serving Japan’s sophisticated bioresearch and pharmaceutical sectors.

The relationship between Curiox and TOMY, built upon mutual trust and technical collaboration, has grown richer through successful sales and deployment of Curiox’s innovative Laminar Wash™ technology across Japan. Recognizing TOMY’s expertise and dedication, Curiox has granted exclusive distribution rights for its cutting-edge Pluto Workstation in Japan. TOMY immediately acquired the Pluto LT model, enabling it to swiftly meet increasing demand from Japan’s leading pharmaceutical companies.

“We are delighted to strengthen our partnership with TOMY, enhancing our ability to deliver Pluto Workstation and advanced solutions to Japan’s prominent pharmaceutical companies and research institutions,” said a Curiox representative for the APAC region.

The relationship between Curiox and TOMY, built upon mutual trust and technical collaboration, has grown richer through successful sales and deployment of Curiox’s innovative Laminar Wash™ technology across Japan. Recognizing TOMY’s expertise and dedication, Curiox has granted exclusive distribution rights for its cutting-edge Pluto Workstation in Japan. TOMY immediately acquired the Pluto LT model, enabling it to swiftly meet increasing demand from Japan’s leading pharmaceutical companies.

About Curiox Biosystems Co. Ltd

Curiox Biosystems Co. Ltd is a rapidly growing global biotechnology company specializing in advanced sample preparation solutions that enhance next-generation therapies. The company leverages expertise in surface chemistry and instrumentation to address life-science research challenges, particularly in miniaturization and automation. Curiox’s innovative technologies boost productivity through sample preparation automation, speeding up therapeutic development. Committed to advancing its proprietary C-FREE™ technology, Curiox enables significant scientific breakthroughs, reinforcing its role as a key player in transforming life sciences research and diagnostics worldwide.